⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

RVTY

Revvity, Inc.

Healthcare · Diagnostics & Research

123.85USD

-3.2300 (-2.54%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY—2.8B2.8B2.9B2.9B3.0B
Q1963.2M674.9M649.9M664.8M711.1M—
Q2895.6M709.1M691.7M720.3M729.7M—
Q3711.8M670.7M684.0M698.9M694.9M—
Q4—695.9M*729.4M*772.1M*759.1M—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY—5.552.202.075.355.89
Q11.404.50.210.350.360—
Q21.42.280.450.460.470—
Q3.670.080.770.4001.29—
Q4—

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

.629*
.771*
.844*
1.61
—